With over $2 billion processed to sites on behalf of sponsors and CROs, DrugDev is uniquely qualified to educate pharma and biotech on the benefits of outsourcing payments.
LONDON UK and PHILADELPHIA PA (PRWEB UK)
28 June 2017
DrugDev understands that for many sites, the top consideration for applying to a clinical study is whether they can trust the sponsor to pay them correctly and on time. As the search for high-performing sites becomes more competitive, it is vital that sponsors and CROs establish payment strategies that encourage sites to work on their studies.
At a complimentary live webinar Thursday, 29 June at 1:30pm BST/8:30am EDT global payments expert Stewart Mackie, DrugDev Vice President, Payments ROW, will offer best practices advice to pharma and biotech organizations so they can attract and keep sites interested in their studies by adopting technology-based solutions to deliver site payments accurately and on time.
Webinar: Why Outsourcing Site Payments Makes Sense
Date: 29 June 2017
Time: 1:30pm BST | 8:30am EDT
Presenter: Stewart Mackie, DrugDev Vice President, Payments ROW
Registration: Register Here
(Free for all attendees)
Attendees of this webinar will learn:
- Positive and negative impacts of payment models on sites
- Pros and cons of each investigator payment model in the industry
- How an efficient payments system can make you sponsor of choice
- Best practices from over 11 years of payments at DrugDev
DrugDev is uniquely qualified to educate pharma and biotech on the benefits of outsourcing payments. Earlier this year, DrugDev announced an industry milestone of over $2 billion in payments processed to sites worldwide on behalf of sponsors and CROs. DrugDev…